Global Cell Signaling Market
The global Cell Signaling Market was valued at USD 2.32 billion in 2016 and is projected to reach USD 4.18 billion by 2025, growing at a CAGR of 6.75% from 2017 to 2025.
With expansion in Genetic make-up based therapeutics and pharmaceuticals, the role of cell signaling pathways and their mechanism have become significant for the R&D purposes. With prevalence of chronic disorders, the market is expected to grow at a high CAGR.
1. Market Drivers
1.1 Rising Incidence of Chronic Diseases
1.2 Availability of Funding for Cell-Based Research
1.3 Technological Advancements in Cell-Based Research Instruments
1.4 Growth of End-Use Industries
2. Market Restraints
2.1 High Cost of Cell Signaling Systems
2.2 Ethical Issues Related to Embryonic Stem Cell Signaling Research
1. Global Cell SignalingMarket, by Product:
1.1.3 Assay Kits
1.1.4 Other Consumables
2. Global Cell SignalingMarket, by Signaling Type:
2.1 Endocrine Signaling
2.2 Paracrine Signaling
2.3 Autocrine Signaling
2.4 Juxtacrine Signaling
2.5 Other Signaling Types
3. Global Cell SignalingMarket, by Pathway:
3.1 AKT Signaling Pathway
3.2 AMPK Signaling Pathway
3.3 ErbB/HER Signaling Pathway
3.4 Hedgehog Signaling Pathway
3.5 JAK/STAT Signaling Pathway
3.6 Notch Signaling Pathway
3.7 NF-KB Signaling Pathway
3.8 Other Signaling Pathways
4. Global Cell Signaling Market, by Technology:
4.2 Flow Cytometry
4.3 Mass Spectrometry
4.4 Western Blotting
4.7 Other Technologies
5. Global Cell Signaling Market, by Application:
5.1 Medical applications
5.2 Research applications
5.2.1 Cancer Research
5.2.2 Immunology Research
5.2.3 Stem Cells Research
5.2.4 Other Research Applications
6. Global Cell Signaling Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
The major players in the market are as follows:
1. Merck KGaA
2. Thermo Fisher Scientific Inc.
3. Becton, Dickinson and Company
4. Beckman Coulter Inc. (A Subsidiary of Danaher Corporation)
5. Bio-Rad Laboratories, Inc.
6. Perkinelmer, Inc
7. Qiagen N.V.
8. Cell Signaling Technology, Inc.
9. Promega Corporation
10. Bio-Techne Corporation
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Cell SignalingMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.